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Abstract
Drug-induced type I hypersensitivity reactions are frequent. 
Sometimes, acute coronary syndrome (ACS) can be registered 
in such patients, which may have a serious impact on the course 
and management of the allergic reaction. Because of potentially 
atypical ACS clinical presentations, the ECG is an obligatory 
diagnostic tool in any allergic reaction. Coronary artery spasm 
is the pathophysiological basis of ACS, triggered by the action 
of potent vasoactive mediators (histamine, neutral proteases, 
arachidonic acid products) released from the cells involved in 
type I hypersensitivity. Allergic angina and allergic myocardial 
infarction are referred to as Kounis Syndrome. 
We describe herein a case of ACS in a patient with registered 
systemic immediate hypersensitivity reaction which developed 
following the muscular administration of diclofenac sodium.
Introduction
Diclofenac sodium (DS) is a frequently used non-
steroidal anti-inflammatory drug (NSAID). Gastrointestinal, 
haematological, hepatic and renal side effects, as well as allergic 
reactions are registered frequently. The hypersensitivity reactions 
with the symptoms and signs of coronary arteries involvement 
(Kounis Syndrome) are not rare, despite the fact that they are not 
frequently documented in the medical literature1,6 Therefore, the 
report of Mori et al.1 on the first two cases of vasospastic angina 
presented after NSAID administration is debatable. Kounis 
Syndrome is the concurrence of ACS with mast cell activation 
induced by allergic or hypersensitivity and anaphylactic or 
anaphylactoid reactions.2,6 In our discussion we review a case 
of ACS in a patient who suffered an anaphylactic reaction after 
the administration of DS. 
Case report
A 66-year-old man was admitted to the CCU of Zemun 
Clinical Hospital after CPR had been performed on him in the 
Casualty Medicine Cubicle. His medical history evidenced the 
parenteral administration of DS in the Casualty Surgical Cubicle 
as he complained of pain in his left toe caused by foot injury 
he had sustained a few days before. He had no medical record 
of drug allergies, nor did he provide any drug allergy data to 
medical stuff prior to DS administration. Several minutes after 
the parenteral administration of DS, he suddenly experienced 
cardio-respiratory arrest, and was immediately transferred 
to the Casualty Medicine Cubicle for resuscitation. The ECG 
recording showed up to 5mm ST segment elevation in inferior 
and entire precordial leads (Figure 1). He was transferred 
to CCU after CPR had been successfully performed (airway 
intubation, oxygen therapy, establishing IV access, precordial 
thump, crystalloid administration). Later on, we received 
his health insurance card only to discover that it contained a 
written warning of DS hypersensitivity. The patient’s family said 
that similar episodes had occurred after the application of DS 
two or three years before, except that he then experienced no 
cardio-respiratory arrest and had no ECG pathological findings. 
The patient had always refused to undergo the recommended 
allergy testing.
At admission to the CCU, the patient was unconscious, 
intubated, with irregular spontaneous respirations, centrally 
and peripherally cyanosed, afebrile. Clinical: raised JVP (1-
2+), apparent pathological venous pulsations. Chest: weak 
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pulmonary sound on auscultation with prolonged expiration, 
diffuse polyphonic wheezing and inspiratory crackles at the lung 
bases. Heart: quiet heart sounds, regular action, PR 110bpm, 
and BP 10.5/6.5kPa (80/50mmHg). With the exception of the 
swelling and bruising of the left toe, other physical examination 
of extremities was regular. 
Laboratory findings. Complete blood count (CBC) 
showed eosinophilia (8%) and neutrophilia (82%), but no 
abnormalities in the count of other blood cells. Biochemical 
analyses showed mild hyperglycemia (7.4mmol/L), whereas 
hepatic, electrolyte, creatin-kinase, BUN and creatine findings 





 90mmHg, and haemoglobin-
oxygen saturation 94%). The urinalysis showed haematuria (a 
urinary catheter inserted). Findings on the chest X-ray showed 
air trapping (pulmonary emphysema), presumably due to the 
excessive smoking habit.
The patient was managed by oxygen, methylprednisolone, 
theophyline, IV nitrates (Nirmin®) and carefully monitored for 
ST elevations. A few hours later, spontaneous respirations were 
restored and the patient gradually regained consciousness. He 
had an almost regressed chest auscultation finding showing 
inspiratory crackles at the lung bases. Four hours after 
admission to the CCU, he was extubated and showed stabilized 
haemodynamic parameters - PR 96bpm, BP 17/11kPa (125/80 
mmHg). On the second day, control laboratory tests revealed 
hyperglycemia (10.1mmol/L), elevated creatine kinase (468 
U/l) and overall serum IgE levels (356 U/l). The measurements 
of serum specific IgE directed to NSAID, serum histamine and 
tryptase levels were not performed (due to the lack of funds 
and equipment for such measurement). Other haematological 
(eosinophils) and biochemical parameters, including Troponin 
I (<0.2ng/ml) were within the reference range. Repeated ECG 
recordings (Figure 2) showed a regular heart rhythm and a rate 
of 84 bpm, with no specific ST-T changes. Echocardiography 
revealed no motility disorders of the heart muscle (EF 53%, trace 
mitral and tricuspid regurgitation). The patient was discharged 
at his own request and refused to undergo the recommended 
exercise stress testing and coronary arteries angiography. Four 
weeks later, the repeated overall serum IgE level showed a 
significant decrease (69 U/l). 
Discussion
The occurrence of ACS is a serious clinical problem, 
despite its being seldom reported in patients with anaphylactic 
responses to drug administration. The mechanism of its 
onset is characterized by coronary arteries spasm due to mast 
cells degranulation and the subsequent release of vasoactive 
mediators.2 Mast cells are recruited to heart tissue and adventitia 
of coronary arteries.3 Released mediators can be preformed 
(histamine, neutral proteases - chymase and tryptase, platelet 
activating factor) or newly synthesized (cytokines, chemokines, 
arachidonic acid products - leukotrienes, prostaglandins). They 
can act either locally and/or systemically, and have important 
roles in the activation and interaction between other cells 
involved in allergic reactions (macrophages, T-lymphocytes, 
endothelial cells).6-8 The most important among the various 
mediators are histamine, serotonin, and leukotrienes, the 
exogenous application of which provoked coronary spasm in 
patients who suffered from vasospastic angina.4,5 Likewise, one 
cannot disregard the inhibition of vasodilative prostaglandin 
production, such as PgI
2
, caused by the NSAIDs influence 
on the enzyme involved in prostaglandin synthesis (cyclo-
oxygenase).1 
Nikolaidis et al.6 described two variants of Kounis syndrome. 
The type I variant, includes patients with normal coronary arteries 
and represents a manifestation of endothelial dysfunction. Type 
II variant of Kounis syndrome includes patients with preexisting 
atheromatous coronary arteries disease. Causes of Kounis 
syndrome include drugs (antibiotics, analgesics, antineoplastics, 
contrast media, corticosteroids, intravenous anesthetics, 
NSAIDs, skin disinfectants, thrombolytics, anticoagulants), 
various conditions (angio-edema, bronchial asthma, urticaria, 
food allergy, exercise induced allergy, mastocytosis, serum 
sickness), and environmental exposures (stings of ants, bees, 
wasps, jellyfish, grass cutting, millet allergy, poison ivy, latex 
contact, shellfish eating, viper venom poisoning).6, 7
To conduct provocative NSAIDs testing in the course of a 
coronary angiography study is not recommended as it may lead 
to potentially fatal anaphylaxis, as well as for ethical reasons. 
Assured of “normal coronary arteries” on angiography, Mori et 
al.1 administered acetylcholine and ergonovine to two patients, 
which provoked coronary arteries spasm, chest pain, and 
specific ECG changes. Our patient was unwilling to undergo 
Figure 1: ECG report at admission Figure 2: ECG report at discharge
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coronary angiography.  Furthermore, he resolutely rejected both 
angiography and exercise stress testing. For this reason, the 
clinical, ECG and serological findings of a significant IgE level 
decrease were taken into account to confirm ACS. 
Conclusion
The manifestations of ACS in drug-induced hypersensitivity 
reactions could be completely atypical and therefore cause 
diagnostic confusions. It is of great importance to ask the patient 
if he is aware of any allergies, and not only drug-related. Before 
any drug administration, it would be prudent to check whether 
there are any medical records of drug hypersensitivities or 
intolerances. Likewise, health authorities must provide allergy 
alert cards. Because of potentially fatal anaphylaxis, drug allergy 
testing is of limited and cautious use. Therefore, even a suspicion 
about drug allergy must be treated seriously. In cases where 
hypersensitivity reactions are developed, ECG must unavoidably 
be recorded. When one encounters poor patient compliance, as 
we did in this case, diagnosis may be established if only some, 
rather than all diagnostic criteria for ACS in hypersensitivity 
reactions, are fulfilled. It is noteworthy that administration of 
mast cell membrane stabilization drugs should be used as a 
therapeutic strategy for patients prone to food induced allergy, 
for atopic patients and such who have already experienced 
allergic angina and/or infarction.9, 10
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